Home » Market News » DirectorsTalk Highlights » Rare cancer linked to breast implant used by millions of women
Oxford BioDynamics

Rare cancer linked to breast implant used by millions of women

A type of breast implant which has been used by millions of women around the world is under scrutiny after French surgeons were advised to stop using it because of a potential link with a rare kind of cancer.

Textured breast implants have been linked with anaplastic large cell lymphoma (ALCL), which forms in the scar capsule around the implant and normally begins with pain and swelling in the breast.

Women who have the implants and capsules removed can make a full recovery, but if left untreated the disease can spread throughout the body and become life-threatening.

 

Oxford BioDynamics Plc (LON: OBD)  is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.